Inhibiting GS-FDH to modulate NO bioactivity
US7179791B2 · kind B2 · utility
15Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2001 |
| Grant date | Feb 20, 2007 |
| Priority date | — |
| Expiry date | Mar 4, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.